9.200
−11,54%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -0.5% | +32.6% | 1 / 3 | +1.8% | -0.78 pp | -0.06 pp | +15.7% | 2.81 | 5.84 | 425 | +1,8% | 11,0 | −0,5% | 5.84 | 7.64 | −23,6% |
| Pts | 0 | 4 | 4 | 0 | 4 | 4 | 4 | -4 | 12 | |||||||
Valuation annotation:Price: 9.200 (close price on 2026-10-19)EPS (TTM): 1.575
Financial charts
1.Revenue & growth
VND bn425Q2/26
1.Revenue & growth
VND bn425Q2/26
2.Profit & growth
VND bn11,0Q2/26
3.Profit mix (Penman)
VND bn46,8Q2/26
4.Margins & cost structure
%8.3%Q2/26
5.Returns & cash cycle
% · days7.6%Q2/26
6.Earnings quality & cash
VND bn-145Q2/26
7.Asset structure
VND bn1.284Q2/26
8.Funding & debt health
VND bn · times1.284Q2/26
9.Revenue backlog
VND bn27,7Q2/26
10.Valuation
times · %7,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %469Q2/26
Adjusted EPS growth, latest quarter
-0.5%
Average adjusted EPS growth, 3 quarters
32.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26